ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 756673 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 756673; 2) Community: the network communities that were significantly associated with the response to NSC 756673; 3) Molecule: the relationships between components within communities and NSC 756673; 4) MDR: the compounds that were significantly associated with the NSC 756673.

NSC Compound Enrichment Correlation
NSC 661748 [6,6'-Bibenzo[6,7]cyclohepta[1,2,3-cd]benzofuran]-4,4',8,8', 10,10'-hexol, 1,1',6,6',7,7',11b,11'b-octahydro-1,1',7,7'- tetrakis(4-hydroxyphenyl)-, [1.alpha.,6.beta.(1'R*,6'S*,7'R*),7.alpha]- 0.0260391472224207 0.13190593
NSC 666767 Null 0.0260391472224207 0.10467396
NSC 671107 Null 0.0260391472224207 0.17173711
NSC 674067 stereoisomer of NSC 674066-O 0.0260391472224207 0.33683243
NSC 678989 Uracil, 1-[1,2-bis(ethoxycarbonyl)ethenyl]-, cis- 0.0260391472224207 0.17525581
NSC 679509 Null 0.0260391472224207 -0.029884946
NSC 682831 Butanimidoyl chloride, N-[[[(3-fluorophenyl)amino] carbonyl]oxy]- 0.0260391472224207 0.19265371
NSC 693985 Thymine, 1-[1,2-bis(ethoxycarbonyl)ethenyl]- 3-propynyl-, (Z)- 0.0260391472224207 0.12210465
NSC 700262 Null 0.0260391472224207 -0.037941473
NSC 713201 Null 0.0260391472224207 0.31743629
Total:35  Current:17    [First] [Prev] [Next] [Last]